Literature DB >> 7317217

Systolic time intervals in measurement of inotropic response to drugs.

B F Johnson, M K Meeran, A Frank, S H Taylor.   

Abstract

During periods of tachycardia induced by atrial pacing in eight patients, moderate increments in dP/dt(max) and (dP/dt)/CPIP (common produced intraventricular pressure) and moderate reductions in left ventricular ejection time (LVET) and Q-S2 were demonstrated. These changes varied between individuals, but reduction in systolic intervals was consistently less than that reported from populations showing a range of resting heart rates. Individual regression formulae relating each variable to paced heart rate were used to calculate rate-dependent and rate-independent changes induced by isoprenaline and ouabain. Despite technical difficulty in precise measurement of systolic intervals, there was an excellent inverse correlation between rate-independent changes in Q-S2 and in both dP/dt(mac) and (dP/dt)/CPIP. Rate-independent change in Q-S2 appears to be a practical, moderately sensitive, and reasonably precise measure of the inotropic effect of a drug which does not radically alter left ventricular end-diastolic pressure or blood pressure. Day-to-day variation in systolic intervals may limit the use of the technique to studies of short duration.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7317217      PMCID: PMC482689          DOI: 10.1136/hrt.46.5.513

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  18 in total

1.  Studies on the first derivative of the ventricular pressure pulse in man.

Authors:  W L GLEASON; E BRAUNWALD
Journal:  J Clin Invest       Date:  1962-01       Impact factor: 14.808

2.  Medical ethics.

Authors:  R Ormrod
Journal:  Br Med J       Date:  1968-04-06

3.  Ejection time by ear densitogram and its derivative. Clinical and physiologic applications.

Authors:  V Quarry-Pigott; R Chirife; D H Spodick
Journal:  Circulation       Date:  1973-08       Impact factor: 29.690

4.  External isovolumic contraction times and left ventricular ejection time-external isovolumic contraction time ratios at rest and after exercise in coronary heart disease.

Authors:  W S Aronow; A F Bowyer; M A Kaplan
Journal:  Circulation       Date:  1971-01       Impact factor: 29.690

5.  Bedside technics for the evaluation of ventricular function in man.

Authors:  A M Weissler; W S Harris; C D Schoenfeld
Journal:  Am J Cardiol       Date:  1969-04       Impact factor: 2.778

6.  Usefulness and limitations of the rate of rise of intraventricular pressure (dp-dt) in the evaluation of myocardial contractility in man.

Authors:  D T Mason
Journal:  Am J Cardiol       Date:  1969-04       Impact factor: 2.778

7.  Postural effects on the noninvasive baselines of ventricular performance.

Authors:  V Q Lance; D H Spodick
Journal:  Cardiology       Date:  1977       Impact factor: 1.869

8.  Measurement of cardiac pre-ejaction period.

Authors:  D H Spodick
Journal:  N Engl J Med       Date:  1977-04-07       Impact factor: 91.245

9.  The effect of steady-state increases in systemic arterial pressure on the duration of left ventricular ejection time.

Authors:  J A Shaver; F W Kroetz; J J Leonard; H W Paley
Journal:  J Clin Invest       Date:  1968-01       Impact factor: 14.808

10.  Effects of adrenergic receptor activation and blockade on the systolic preejection period, heart rate, and arterial pressure in man.

Authors:  W S Harris; C D Schoenfeld; A M Weissler
Journal:  J Clin Invest       Date:  1967-11       Impact factor: 14.808

View more
  13 in total

1.  The cardiovascular effects of xamoterol, a beta 1-adrenoceptor partial agonist, in healthy volunteers at rest.

Authors:  T Hashimoto; A Shiina; T Toyo-Oka; S Hosoda; K Kondo
Journal:  Br J Clin Pharmacol       Date:  1986-03       Impact factor: 4.335

Review 2.  Xamoterol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use.

Authors:  R Furlong; R N Brogden
Journal:  Drugs       Date:  1988-10       Impact factor: 9.546

3.  Cardiovascular (ECG and systolic time intervals) and anticholinergic effects of repeated doses of femoxetine--a comparison with amitriptyline and placebo in healthy men.

Authors:  S J Warrington; P Turner; B K Skrumsager
Journal:  Br J Clin Pharmacol       Date:  1989-03       Impact factor: 4.335

4.  The effect of a new inotropic agent, DPI 201-106, on systolic time intervals and the electrocardiogram in healthy subjects.

Authors:  P C Rüegg; E Nüesch
Journal:  Br J Clin Pharmacol       Date:  1987-10       Impact factor: 4.335

5.  Systolic time intervals in evaluation of the negative inotropic effect after single oral doses of mexiletine and disopyramide.

Authors:  D Rousson; C Piolat; J Galleyrand; S Ferry; J P Boissel
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

Review 6.  Systolic time intervals in clinical pharmacology.

Authors:  Q Li; G G Belz
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

Review 7.  Systolic time intervals: a review of the method in the non-invasive investigation of cardiac function in health, disease and clinical pharmacology.

Authors:  S Hassan; P Turner
Journal:  Postgrad Med J       Date:  1983-07       Impact factor: 2.401

8.  Uncorrected pre-ejection period: a simple non-invasive measurement for pharmacodynamic screening of inotropic activity.

Authors:  D Rousson; J Galleyrand; M Silie; J P Boissel
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

9.  Acute cardiovascular effects of ethanol A controlled non-invasive study.

Authors:  M Kupari
Journal:  Br Heart J       Date:  1983-02

10.  Indices of cardiac function during treatment with betamimetic drugs (fenoterol and hexoprenaline).

Authors:  U Siekmann; L Heilmann; M Irmer
Journal:  Arch Gynecol       Date:  1983
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.